Nefecon for IgAN, The NefIgArd Part B Trial

Nefecon (coated budesonide) is the first drug labeled for IgA nephropathy and the approval path. A 9-month reduction in proteinuria followed by 2-year glomerular filtration rate data set the stage for the glomerulonephritis renaissance we are currently living through.